Patents by Inventor Akifumi Tsuchiura

Akifumi Tsuchiura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
    Publication number: 20190365776
    Abstract: Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.
    Type: Application
    Filed: August 16, 2019
    Publication date: December 5, 2019
    Applicants: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, KOWA COMPANY, LTD.
    Inventors: Tatsuro Ishibashi, Shintaro Nakao, Ryoichi Arita, Ken Mizuno, Akifumi Tsuchiura
  • Therapeutic agent for ocular fundus disease
    Patent number: 10426783
    Abstract: Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: October 1, 2019
    Assignees: KYUSHU UNIVERSITY, NAT'L UNIVERSITY CORPORATION, KOWA COMPANY, LTD.
    Inventors: Tatsuro Ishibashi, Shintaro Nakao, Ryoichi Arita, Ken Mizuno, Akifumi Tsuchiura
  • Corneal thickness modulating agent
    Patent number: 10034885
    Abstract: The present invention provides a novel corneal thickness modulating agent. The present invention pertains to a corneal thickness modulating agent containing 1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof or a solvate thereof.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: July 31, 2018
    Assignee: KOWA COMPANY, LTD.
    Inventors: Hiroyuki Takahashi, Kiyoshi Toya, Akifumi Tsuchiura
  • CORNEAL THICKNESS ADJUSTMENT AGENT
    Publication number: 20170290840
    Abstract: The present invention provides a novel corneal thickness modulating agent. The present invention pertains to a corneal thickness modulating agent containing 1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof or a solvate thereof.
    Type: Application
    Filed: September 24, 2015
    Publication date: October 12, 2017
    Applicant: KOWA COMPANY, LTD.
    Inventors: Hiroyuki Takahashi, Kiyoshi Toya, Akifumi Tsuchiura
  • THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
    Publication number: 20170100409
    Abstract: Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 13, 2017
    Applicants: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, KOWA COMPANY, LTD.
    Inventors: Tatsuro Ishibashi, Shintaro Nakao, Ryoichi Arita, Ken Mizuno, Akifumi Tsuchiura
  • THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
    Publication number: 20160339018
    Abstract: Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.
    Type: Application
    Filed: March 3, 2014
    Publication date: November 24, 2016
    Applicants: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, KOWA COMPANY, LTD.
    Inventors: Tatsuro Ishibashi, Shintaro Nakao, Ryoichi Arita, Ken Mizuno, Akifumi Tsuchiura
  • THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
    Publication number: 20140378441
    Abstract: Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.
    Type: Application
    Filed: September 9, 2014
    Publication date: December 25, 2014
    Applicants: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, KOWA COMPANY, LTD.
    Inventors: Tatsuro Ishibashi, Shintaro Nakao, Ryoichi Arita, Ken Mizuno, Akifumi Tsuchiura